Pes Anserine Bursitis Medication
- Author: Robert F LaPrade, MD, PhD; Chief Editor: Sherwin SW Ho, MD more...
Medication Summary
In general, medications are not frequently used to treat pes anserine bursitis. In cases in which it may be warranted to help alleviate symptoms, the addition of an over-the-counter or prescribed anti-inflammatory medication may be indicated.
Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Class Summary
NSAIDs have analgesic and anti-inflammatory activities. Their mechanism of action is not known, but they may inhibit cyclooxygenase activity and prostaglandin synthesis. Other mechanisms may exist as well, such as inhibition of leukotriene synthesis, lysosomal enzyme release, lipoxygenase activity, neutrophil aggregation, and various cell membrane functions.
Ibuprofen (Motrin, Ibuprin)
DOC for patients with mild to moderate pain. Inhibits inflammatory reactions and pain by decreasing prostaglandin synthesis.
Ketoprofen (Orudis, Oruvail, Actron)
For relief of mild to moderate pain and inflammation.
Small dosages are initially indicated in small and elderly patients and in those with renal or liver disease.
Doses over 75 mg do not increase therapeutic effects. Administer high doses with caution and closely observe patient for response.
Naproxen (Aleve, Naprosyn, Anaprox, Naprelan)
For relief of mild to moderate pain; inhibits inflammatory reactions and pain by decreasing activity of cyclooxygenase, which results in a decrease of prostaglandin synthesis.
Anesthetic (Local) and Corticosteroid Combinations
Class Summary
Local anesthetics stabilize neuronal membranes and prevent the initiation and transmission of nerve impulses, thereby producing the local anesthetic action. Corticosteroids have anti-inflammatory properties and cause profound and varied metabolic effects. In addition, corticosteroids modify the body's immune response to diverse stimuli.
Celestone and 1% lidocaine
Compounded medication consisting of 0.5 mL of Celestone and 2.0 mL of 1% lidocaine without epinephrine.
Wood LR, Peat G, Thomas E, Duncan R. The contribution of selected non-articular conditions to knee pain severity and associated disability in older adults. Osteoarthritis Cartilage. Jun 2008;16(6):647-53. [Medline].
Helfenstein M Jr, Kuromoto J. Anserine Syndrome. Review of Brazillian Reumatology. June/2010;50:313-327. [Medline].
Cohen SE, Mahul O, Meir R, Rubinow A. Anserine bursitis and noninsulin dependent diabetes mellitus. Journal of Rheumatology. 1997;24:2162-2165. [Medline].
Unlu Z, Ozmen B, Taethan S, Boyvoda S, Goktan C. Ultrasonographic evaluation of pes anserinus tendino-bursitis in patients with type 2 diabetes mellitus. Journal of Rheumatology. 2003;30:352-354. [Medline].
Mochizuki T, Akita K, Muneta T, Sato T. Pes anserinus: layered supportive structure on the medial side of the knee. Clin Anat. Jan 2004;17(1):50-4. [Medline].
Kang I, Han SW. Anserine bursitis in patients with osteoarthritis of the knee. South Med J. Feb/2000;93:207-209. [Medline].
Forbes JR, Helms CA, Janzen DL. Acute pes anserine bursitis: MR imaging. Radiology. Feb 1995;194(2):525-7. [Medline]. [Full Text].
Forbes JR, Helms CA, Janzen DL. Acute pes anserine bursitis: MR imaging. Radiology. 1995;194:525-527. [Medline].
Butcher JD, Salzman KL, Lillegard WA. Lower extremity bursitis. Am Fam Physician. May 15 1996;53(7):2317-24. [Medline].
Alvarez-Nemegyei J. Risk factors for pes anserinus tendinitis/bursitis syndrome: a case control study. J Clin Rheumatol. Apr 2007;13(2):63-5. [Medline].
Clapp A, Trecek J, Joyce M, Sundaram M. Radiologic case study. Pes anserine bursitis. Orthopedics. Apr 2008;31(4):306, 407-8. [Medline].
Cox JS, Blanda JB. Peripatellar pathologies. In: Delee JC, Drez D, Stanitski CL, eds. Orthopaedic Sports Medicine: Principles and Practice. Vol 3. Philadelphia, Pa: WB Saunders Co; 1994:1249-60.
Hemler DE, Ward WK, Karstetter KW, Bryant PM. Saphenous nerve entrapment caused by pes anserine bursitis mimicking stress fracture of the tibia. Arch Phys Med Rehabil. Apr 1991;72(5):336-7. [Medline].
Kelly SS, Erpelding JM, Kobs J. Knee and lower leg. In: Snider RK, ed. Essentials of Musculoskeletal Care. Rosemont, Ill: American Academy of Orthopaedic Surgeons; 1997:306-65.
Marquis AM. Pes anserine bursitis. ONA J. Oct 1979;6(10):418-9. [Medline].
Marra MD, Crema MD, Chung M, et al. MRI features of cystic lesions around the knee. Knee. Dec 2008;15(6):423-38. [Medline].
Medical Economics. Physician's Desk Reference. 54th ed. Montvale, NJ: Thomson Healthcare; 2000.
Mercier LR, Pettid FJ, Tamisiea DF, eds. The knee. Practical Orthopedics. 4th ed. St. Louis, Mo: Mosby-Year Book; 1995:226-7.
Muchnick J, Sundaram M. Radiologic case study. Pes anserine bursitis. Orthopedics. Nov 1997;20(11):1100; 1092-4. [Medline].
Nokes SR, Smith T. Acute pes anserine bursitis. J Ark Med Soc. Nov 2007;104(5):112. [Medline].
Rennie WJ, Saifuddin A. Pes anserine bursitis: incidence in symptomatic knees and clinical presentation. Skeletal Radiol. Jul 2005;34(7):395-8. [Medline].
Seibel MO. Neuromuscular examination. In: Valmassy RL, ed. Clinical Biomechanics of the Lower Extremities. St. Louis, Mo: Mosby-Year Book; 1996:208-20.
Unlu Z, Ozmen B, Tarhan S, Boyvoda S, Goktan C. Ultrasonographic evaluation of pes anserinus tendino-bursitis in patients with type 2 diabetes mellitus. J Rheumatol. Feb 2003;30(2):352-4. [Medline].
Yoon HS, Kim SE, Suh YR, Seo YI, Kim HA. Correlation between ultrasonographic findings and the response to corticosteroid injection in pes anserinus tendinobursitis syndrome in knee osteoarthritis patients. J Korean Med Sci. Feb 2005;20(1):109-12. [Medline]. [Full Text].
Zaffagnini S, Golanò P, Farinas O, et al. Vascularity and neuroreceptors of the pes anserinus: anatomic study. Clin Anat. Jan 2003;16(1):19-24. [Medline].

